GPR183 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.855200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.806800E-01
Normal-vs-Stage2
4.043800E-01
Normal-vs-Stage3
3.700800E-01
Normal-vs-Stage4
3.788000E-01
Stage1-vs-Stage2
3.238100E-02
Stage1-vs-Stage3
1.317650E-01
Stage1-vs-Stage4
1.311400E-01
Stage2-vs-Stage3
4.260000E-01
Stage2-vs-Stage4
8.561000E-01
Stage3-vs-Stage4
8.981800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.841400E-01
Normal-vs-AfricanAmerican
6.629800E-01
Normal-vs-Asian
2.814800E-01
Caucasian-vs-AfricanAmerican
4.288000E-01
Caucasian-vs-Asian
1.241800E-01
AfricanAmerican-vs-Asian
2.246200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.686600E-01
Normal-vs-Female
4.096600E-01
Male-vs-Female
3.465600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.025400E-01
Normal-vs-Age(41-60Yrs)
1.450580E-01
Normal-vs-Age(61-80Yrs)
3.527600E-01
Normal-vs-Age(81-100Yrs)
1.012640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.671400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.748000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.483600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.570000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.374400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.694800E-01
Normal-vs-Daily Drinker
3.328800E-01
Normal-vs-Weekly Drinker
3.165200E-01
Normal-vs-Occasional Drinker
3.333200E-01
Normal-vs-Social Drinker
3.608800E-01
Non Drinker-vs-Daily Drinker
5.438400E-01
Non Drinker-vs-Weekly Drinker
3.087400E-01
Non Drinker-vs-Occasional Drinker
5.622400E-01
Non Drinker-vs-Social Drinker
8.870600E-01
Daily Drinker-vs-Weekly Drinker
7.873000E-01
Daily Drinker-vs-Occasional Drinker
9.924000E-01
Daily Drinker-vs-Social Drinker
6.839600E-01
Weekly Drinker-vs-Occasional Drinker
8.119200E-01
Weekly Drinker-vs-Social Drinker
4.571000E-01
Occasional Drinker-vs-Social Drinker
6.898000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.279800E-01
Normal-vs-Grade 2
8.545400E-01
Normal-vs-Grade 3
9.733200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.002600E-01
Grade 1-vs-Grade 3
8.129200E-01
Grade 1-vs-Grade 4
9.279800E-01
Grade 2-vs-Grade 3
3.733600E-01
Grade 2-vs-Grade 4
8.545400E-01
Grade 3-vs-Grade 4
9.733200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.328000E-02
Normal-vs-NonDiabetic
3.456800E-01
Diabetic-vs-NonDiabetic
1.021590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.110600E-01
Normal-vs-NoPancreatitis
3.796000E-01
Pancreatitis-vs-NoPancreatitis
9.832200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.560400E-01
Normal-vs-N1
4.082000E-01
N0-vs-N1
2.549600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.586170E-01
Normal-vs-TP53-NonMutant
2.668200E-02
TP53-Mutant-vs-TP53-NonMutant
8.005900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
